T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Omeros
OMER
$287M
| $140K | ﹤0.01% |
35,181
| – | – |
|
|
NXDR
2752
Nextdoor Holdings
NXDR
$778M
| $139K | ﹤0.01% |
55,650
-178,207
| -76% | -$445K |
|
2753
The Beauty Health Co
SKIN
$296M
| $138K | ﹤0.01% |
95,747
+19,300
| +25% | +$27.8K |
|
|
TSVT
2754
DELISTED
2seventy bio
TSVT
| $138K | ﹤0.01% |
29,212
+283
| +1% | +$1.34K |
|
|
URG
2755
Ur-Energy
URG
$529M
| $136K | ﹤0.01% |
113,738
+25,945
| +30% | +$31K |
|
2756
Cardiff Oncology
CRDF
$148M
| $132K | ﹤0.01% |
49,237
| – | – |
|
2757
MindMed
MNMD
$714M
| $131K | ﹤0.01% |
22,952
| – | – |
|
2758
MaxCyte
MXCT
$150M
| $130K | ﹤0.01% |
33,405
| – | – |
|
2759
First Foundation Inc
FFWM
$493M
| $129K | ﹤0.01% |
20,574
+4,173
| +25% | +$26.2K |
|
2760
Groupon
GRPN
$920M
| $129K | ﹤0.01% |
13,100
| – | – |
|
2761
OmniAb
OABI
$229M
| $129K | ﹤0.01% |
30,267
+716
| +2% | +$3.05K |
|
2762
Rimini Street
RMNI
$425M
| $129K | ﹤0.01% |
69,429
| – | – |
|
2763
Fulcrum Therapeutics
FULC
$393M
| $128K | ﹤0.01% |
35,712
| – | – |
|
2764
Citizens
CIA
$271M
| $127K | ﹤0.01% |
34,900
| – | – |
|
2765
Berry Corp
BRY
$248M
| $126K | ﹤0.01% |
24,469
+292
| +1% | +$1.5K |
|
2766
Cardlytics
CDLX
$48.5M
| $126K | ﹤0.01% |
39,274
+7,700
| +24% | +$24.7K |
|
2767
Tango Therapeutics
TNGX
$758M
| $125K | ﹤0.01% |
16,185
+951
| +6% | +$7.35K |
|
2768
Getty Images
GETY
$788M
| $123K | ﹤0.01% |
32,071
| – | – |
|
2769
Mercer International
MERC
$214M
| $123K | ﹤0.01% |
18,123
| – | – |
|
2770
Trinseo
TSE
$86.3M
| $123K | ﹤0.01% |
23,900
| – | – |
|
2771
Atomera
ATOM
$108M
| $121K | ﹤0.01% |
45,700
+12,200
| +36% | +$32.3K |
|
|
IAUX
2772
i-80 Gold Corp
IAUX
$692M
| $121K | ﹤0.01% |
103,770
+20,706
| +25% | +$24.1K |
|
2773
Taysha Gene Therapies
TSHA
$884M
| $121K | ﹤0.01% |
59,719
-1,216,859
| -95% | -$2.47M |
|
2774
Inovio Pharmaceuticals
INO
$153M
| $120K | ﹤0.01% |
20,652
| – | – |
|
2775
Ventyx Biosciences
VTYX
$170M
| $120K | ﹤0.01% |
54,902
+2,169
| +4% | +$4.74K |
|